Luana Pesco Koplowitz, MD, PhD., FCP, FFPM
Translational Medicine/Clinical Pharmacology (Adult and Pediatric)
Luana Pesco Koplowitz received her M.D. from Rutgers Medical School and her Ph.D. from Rutgers College of Pharmacy and Columbia Pacific University. She is a fellow of the American College of Clinical Pharmacology and also a member and fellow of the Faculty of Pharmaceutical Medicine of the United Kingdom.
Dr. Pesco Koplowitz is Chief Medical & Scientific Officer of DUCK FLATS Pharma, (Flemington, New Jersey), which specializes in adult and pediatric translational medicine, clinical pharmacokinetics, and nonclinical development in all therapeutic areas, including oncology. Dr. Pesco Koplowitz has received numerous awards in clinical research throughout her career. She has served on the FDA/PhRMA QT Working Group Committee. Since 2007, she has been a member of the Advisory Committee of the FDA Cardiac Safety Research Consortium (CSRC). Since 2015, she is also an invited member of the International Neonatal Consortium of the Critical Path Institute for FDA/EMA/PMDA.
She is a frequently invited speaker and lecturer in overall drug development and regulatory strategy in adult and pediatric patients, translational medicine, neonatal medicine, clinical pharmacology, and cardiovascular safety.
Dr. Pesco Koplowitz has been responsible for numerous successful INDs and NDAs/CTDs in multiple therapeutic areas during her 30-plus year career and holds several use patents in the treatment of various diseases. She is author or co-author of over 30 publications and is a reviewer for several clinical pharmacology, cardiology, and pediatric medical journals.